Document is current
Any future updates will be listed below
-
Authors
Haynes, Winston A.
Kamath, Kathy https://orcid.org/0000-0001-6143-3414
Bozekowski, Joel
Baum-Jones, Elisabeth
Campbell, Melissa
Casanovas-Massana, Arnau
Daugherty, Patrick S.
Dela Cruz, Charles S.
Dhal, Abhilash
Farhadian, Shelli F. https://orcid.org/0000-0001-7230-1409
Fitzgibbons, Lynn
Fournier, John
Jhatro, Michael https://orcid.org/0000-0002-6694-9679
Jordan, Gregory https://orcid.org/0000-0001-5777-1568
Klein, Jon https://orcid.org/0000-0002-3552-7684
Lucas, Carolina https://orcid.org/0000-0003-4590-2756
Kessler, Debra
Luchsinger, Larry L. https://orcid.org/0000-0002-0063-1764
Martinez, Brian
Catherine Muenker, M. https://orcid.org/0000-0002-0450-0868
Pischel, Lauren https://orcid.org/0000-0002-7697-0084
Reifert, Jack
Sawyer, Jaymie R.
Waitz, Rebecca https://orcid.org/0000-0003-1966-538X
Wunder, Elsio A. Jr.
Zhang, Minlu
,
Anastasio, Kelly
Askenase, Michael H.
Balkcom, Natasha C.
Batsu, Maria
Bermejo, Santos
Brower, Kristina
Bucklin, Molly L.
Cahill, Staci
Cao, Yiyun
Chiorazzi, Michael
Chun, Caitlin J.
Datta, Rupak
DeIuliis, Giuseppe
Dorgay, Coriann E.
Earnest, Rebecca
Fournier, John
Geng, Bertie
Handoko, Ryan
Khoury-Hanold, William
Herbst, Roy
Knaggs, Lynda
Kuang, Maxine
Lapidus, Sarah
Lin, Zitong
Lu, Peiwen
Mao, Tianyang
Martin, Anjelica
Matos, Irene
McDonald, David
Minasyan, Maksym
Moore, Adam J.
Naushad, Nida
Nelson, Allison
Nouws, Jessica
Nunez, Angela
Park, Hong-Jai
Peng, Xiaohua
Robertson, Alexander James
Rice, Tyler
Rose, Kadi-Ann
Schulz, Wade
Sewanan, Lorenzo
Sharma, Lokesh
Shepard, Denise
Silva, Julio
Simonov, Michael
Smolgovsky, Mikhail
Sonnert, Nicole
Srivathsan, Ariktha
Strong, Yvette
Todeasa, Codruta
Valdez, Jordan
Velazquez, Sofia
Vijayakumar, Pavithra
White, Elizabeth B.
Zhao, Alice
Iwasaki, Akiko https://orcid.org/0000-0002-7824-9856
Ko, Albert
Shon, John C. https://orcid.org/0000-0001-9465-6286
- License Information
-
More Information
Article History
Received: 25 February 2021
Accepted: 22 October 2021
First Online: 22 November 2021
Competing interests
: The authors declare the following competing interests: employment and personal financial interests including stock options at Serimmune, In: W.A.H., K.K., J.B., E.B.J., P.S.D., A.D., M.J., G.J., B.M., J.R., J.R.S., R.W., M.Z., J.C.S. A.K. reports grant support from Regeneron and Merck for COVID-19 studies, contract and consulting fees from Tata for diagnostics development, honoraria for a COVID-19 lecture from Harvard University, and a research gift from Serimmune. Serimmune has also submitted the following US Patent Application 63/114,939 SARS-CoV-2 Serum Antibody Profiling SUI-009PR4. The remaining authors declare no competing interests.
